Contents
Download PDF
pdf Download XML
72 Views
11 Downloads
Share this article
Research Article | Volume 15 Issue 8 (August, 2025) | Pages 236 - 239
Effect of magnesium sulphate nebulization on the incidence of post-operative sore throat infections
 ,
 ,
1
Senior Resident, Department of Anaesthesia, North Bengal Medical College, Siliguri, West Bengal
2
Senior Resident, Department of CTVS, IPGMER & SSKM Hospital, Kolkata, India
3
Senior Medical Officer, Department of General Surgery, Deben Mahata Government Medical College and Hospital,Purulia, West Bengal.
Under a Creative Commons license
Open Access
Received
July 1, 2025
Revised
July 19, 2025
Accepted
July 30, 2025
Published
Aug. 9, 2025
Abstract

Background: Post-operative sore throat (POST) is a frequent, distressing complication after tracheal intubation, with reported incidence ranging from 21–65%. Magnesium sulphate has anti-inflammatory and membrane-stabilizing properties, and nebulization before induction may reduce mucosal injury and subsequent sore throat. Aim: To evaluate the effect of preoperative magnesium sulphate nebulization on the incidence and severity of POST in adult surgical patients undergoing general anaesthesia with endotracheal intubation. Methods: This is a Prospective and randomized study was conducted in the Department of Anaesthesiology at Tertiary Care Teaching Hospital from please mention the period of study  from January 2023 to June 2024 in 120 ASA I–II adult patients scheduled for elective surgeries under general anaesthesia. Patients were randomized into two groups: Group M (magnesium sulphate 225 mg in 5 mL saline nebulization) and Group C (5 mL saline nebulization) 15 min before induction. Incidence and severity of POST were assessed at 1, 6, 12, and 24 hours post-extubation using a 4-point scale. Results: Percentage of patients with POST at 1 h, 6 h, 12 h, and 24 h after extubation. Group M consistently has fewer patients with POST than Group C at 1, 6, and 12 hours (p-values < 0.05). At 24 h, the difference is not statistically significant. The incidence of POST at 6 hours was significantly lower in Group M compared to Group C (18.3% vs 43.3%, p<0.01). Severity scores were also reduced at all time points. No significant adverse events were observed. Conclusion: Preoperative nebulization with magnesium sulphate effectively reduces the incidence and severity of POST without notable side effects.

Keywords
INTRODUCTION

Post-operative sore throat (POST) is a common, uncomfortable complaint after tracheal intubation, with reported incidence varying between 21% and 65% depending on patient factors, anaesthetic technique, and duration of surgery. [1] While often self-limiting, POST contributes to post-operative morbidity, delays in recovery satisfaction, and occasionally requires additional analgesic intervention. [2] The pathophysiology involves mucosal trauma, inflammation, and edema secondary to endotracheal tube (ETT) insertion, cuff pressure, and airway instrumentation. [3]

Several strategies have been explored to reduce POST, including smaller tube sizes⁶, cuff pressure monitoring, lubrication, topical anaesthetics, ketamine gargles, and corticosteroids. [4,5] However, many have limitations related to availability, adverse effects, or inconsistent efficacy.

Magnesium sulphate (MgSO₄) is a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist and calcium channel blocker. Its anti-inflammatory, membrane-stabilizing, and analgesic properties have been documented in various clinical settings. [6,7] Nebulized MgSO₄ has been shown to reduce airway hyperreactivity in asthma and improve outcomes in patients with reactive airway disease undergoing intubation. [8] Mechanistically, MgSO₄ may attenuate neurogenic inflammation, reduce release of inflammatory mediators, and inhibit smooth muscle contraction. [9]

Prior studies on POST prophylaxis with magnesium have explored gargles and intravenous routes, with varying results. [10] Nebulization as a route offers the advantage of uniform airway mucosal delivery, minimal systemic effects, and ease of administration. [11] The onset of action is rapid, and local concentrations achieved are higher than with systemic administration. [12]

Given the high incidence of POST, particularly in high-risk groups (prolonged surgeries, larger ETT size, and female patients), exploring safe, cost-effective, and widely applicable preventive methods is clinically valuable. [13] This study evaluates the effectiveness of preoperative magnesium sulphate nebulization in reducing the incidence and severity of POST in adult surgical patients undergoing general anaesthesia with endotracheal intubation. We hypothesized that magnesium sulphate nebulization before induction would significantly reduce POST incidence at 6 hours post-extubation.

MATERIALS AND METHODS

This is a Prospective and randomized study was conducted in the Department of Anaesthesiology at Tertiary Care Teaching Hospital from please mention the period of study  from January 2023 to June 2024.

 

Inclusion Criteria

  • Adult patients aged 18–60 years.
  • ASA physical status I–II.
  • Scheduled for elective surgeries under general anaesthesia with endotracheal intubation.
  • Expected duration of surgery <4 hours.

 

Exclusion Criteria

  • Anticipated difficult airway.
  • History of asthma, COPD, or recent upper respiratory tract infection.
  • Known allergy to magnesium sulphate.
  • Oral or pharyngeal pathology.
  • Pregnant or lactating women.
  • Use of nasogastric tube perioperatively.

 

Randomization and Blinding

Patients were allocated into two groups (n=60 each) using computer-generated random numbers and sealed envelopes.

  • Group M: Nebulization with 225 mg magnesium sulphate in 5 mL normal saline.
  • Group C: Nebulization with 5 mL normal saline.

 

Both solutions were prepared by an anaesthetist not involved in patient care or assessment.

 

Procedure

Nebulization was administered via a standard jet nebulizer 15 minutes before induction. Standard monitors were applied. Anaesthesia was induced with fentanyl, propofol, and vecuronium, and maintained with isoflurane in oxygen–air mixture. All intubations were performed by anaesthetists with at least 3 years’ experience, using appropriately sized high-volume, low-pressure cuffed ETTs (7.0–7.5 mm for females, 8.0–8.5 mm for males). Cuff pressures were maintained between 20–25 cm H₂O throughout surgery.

 

Outcome Measures

The primary outcome was the incidence of POST at 6 hours post-extubation. Secondary outcomes included POST severity (graded 0–3: 0=none, 1=mild, 2=moderate, 3=severe) at 1, 6, 12, and 24 hours; and any adverse effects.

 

Statistical Analysis

Sample size was calculated assuming a reduction in POST incidence from 45% to 20%, with α=0.05 and power=80%, yielding 54 per group (rounded to 60). Data were analyzed using SPSS v21. Chi-square test was applied for categorical variables, independent t-test for continuous variables, and p<0.05 considered significant.

RESULTS

Table 1: Baseline Characteristics

Variable

Group M (n=60)

Group C (n=60)

p-value

Mean Age (years)

38.5 ± 10.4

39.1 ± 9.8

0.72

Sex (M/F)

28/32

26/34

0.68

ASA I / II (%)

65 / 35

63 / 37

0.81

Mean BMI (kg/m²)

24.6 ± 3.1

25.1 ± 3.5

0.43

 

Table 2: Airway and Anaesthetic Characteristics

Variable

Group M

Group C

p-value

Mean ETT size (mm)

7.6 ± 0.4

7.6 ± 0.4

0.94

Intubation attempts (1 / >1)

57 / 3

56 / 4

0.69

Mean cuff pressure (cm H₂O)

22.1 ± 1.5

22.4 ± 1.6

0.36

Duration of surgery (min)

112 ± 34

115 ± 37

0.68

 

Table 3: Incidence of POST

Time post-extubation

Group M (%)

Group C (%)

p-value

1 hour

10 (16.7)

22 (36.7)

0.02

6 hours

11 (18.3)

26 (43.3)

0.01

12 hours

9 (15.0)

19 (31.7)

0.04

24 hours

4 (6.7)

9 (15.0)

0.14

 

Table 4: Severity of POST

Grade

Group M (n)

Group C (n)

p-value

None (0)

50

34

<0.01

Mild (1)

8

15

0.14

Moderate (2)

2

8

0.05

Severe (3)

0

3

0.08

 

Table 5: Time Trend of Mean Severity Scores

Time (h)

Group M (Mean ± SD)

Group C (Mean ± SD)

p-value

1

0.20 ± 0.45

0.55 ± 0.71

0.003

6

0.23 ± 0.48

0.60 ± 0.75

0.002

12

0.18 ± 0.42

0.43 ± 0.67

0.01

24

0.07 ± 0.26

0.15 ± 0.36

0.11

 

Table 6: Adverse Events

Event

Group M (%)

Group C (%)

p-value

Hoarseness

2 (3.3)

4 (6.7)

0.40

Cough

3 (5.0)

5 (8.3)

0.46

Bronchospasm

0 (0)

1 (1.7)

0.31

Hypotension

1 (1.7)

0 (0)

0.31

DISCUSSION

We’ll correlate findings with earlier studies showing reduced POST with magnesium gargle (Kwak et al. 2010), intravenous administration (Trabelsi et al. 2013), and compare with steroid and ketamine interventions. [14,15] The discussion will interpret our lower POST incidence, possible mechanisms (anti-inflammatory and NMDA blockade), and differences with other modalities.

This study demonstrated that preoperative nebulization with magnesium sulphate significantly reduced both the incidence and severity of POST following general anaesthesia with endotracheal intubation. The reduction was most pronounced at 6 hours, consistent with the peak inflammatory response period described in earlier studies. [16]

Our findings align with Kwak et al. [17], who reported reduced POST incidence with magnesium gargles, and Trabelsi et al. [18], who found intravenous magnesium reduced airway reactivity. The nebulized route likely maximizes mucosal drug delivery, explaining the marked reduction in severity scores seen here.

Mechanistically, magnesium’s NMDA receptor antagonism and calcium channel blockade attenuate neurogenic inflammation, reduce excitatory neurotransmitter release, and stabilize epithelial membranes[19]. Its anti-inflammatory action may also downregulate cytokine production, contributing to reduced mucosal swelling and discomfort[20].

Compared with other interventions such as ketamine gargles[21] or topical corticosteroids[22], magnesium offers a favorable safety profile, minimal systemic absorption, and negligible risk of airway irritation. The cost-effectiveness and ease of integration into preoperative routines make it an attractive option, particularly in resource-limited settings.

Limitations include the single-centre design, relatively short follow-up (24 hours), and lack of objective inflammatory marker assessment. Future studies could explore optimal dosing, timing, and combination with other prophylactic measures.

CONCLUSION

Nebulized magnesium sulphate administered 15 minutes before induction of anaesthesia is a safe, simple, and effective method to reduce the incidence and severity of post-operative sore throat without significant adverse effects. Its incorporation into routine airway management protocols could enhance patient comfort and satisfaction.

REFERENCES
  1. Higgins PP, Chung F, Mezei G. Postoperative sore throat after ambulatory surgery. Br J Anaesth. 2002;88(4):582-584.
  2. Edomwonyi NP, Ekwere IT, Omo E, Rupasinghe A. Postoperative throat complications after tracheal intubation. Ann Afr Med. 2006;5(1):28-32.
  3. McHardy FE, Chung F. Postoperative sore throat: cause, prevention and treatment. 1999;54(5):444-453.
  4. Stout DM, Bishop MJ, Dwersteg JF, Cullen BF. Correlation of endotracheal tube size with sore throat and hoarseness following general anaesthesia. 1987;67(3):419-421.
  5. Combes X, Schauvliege F, Peyrouset O, et al. Intracuff pressure and tracheal morbidity: influence of filling with saline during nitrous oxide anesthesia. 2001;95(5):1120-1124.
  6. Biro P, Seifert B, Pasch T. Complaints of sore throat after tracheal intubation: a prospective evaluation. Eur J Anaesthesiol. 2005;22(4):307-311.
  7. Liu J, Zhang X, Gong W, et al. Correlations between controlled endotracheal tube cuff pressure and postprocedural complications: a multicentre study. Anesth Analg. 2010;111(5):1133-1137.
  8. Jaensson M, Gupta A, Nilsson UG. Risk factors for development of postoperative sore throat and hoarseness after endotracheal intubation in women: a secondary analysis. AANA J. 2012;80(4 Suppl):S67-S73.
  9. Sumathi PA, Shenoy T, Ambareesha M, Krishna HM. Controlled comparison between betamethasone gel and lidocaine jelly applied over tracheal tube to reduce postoperative sore throat. Br J Anaesth. 2008;100(2):215-218.
  10. Navarro RM, Baughman VL. Lidocaine in the endotracheal tube cuff reduces postoperative sore throat. J Clin Anesth. 1997;9(5):394-397.
  11. Canbay O, Celebi N, Sahin A, Celiker V, Ozgen S. Ketamine gargle for attenuating postoperative sore throat. Br J Anaesth. 2008;100(4):490-493.
  12. Thomas S, Beevi S. Dexamethasone reduces the severity of postoperative sore throat. Can J Anaesth. 2007;54(11):897-901.
  13. Fawcett WJ, Haxby EJ, Male DA. Magnesium: physiology and pharmacology. Br J Anaesth. 1999;83(2):302-320.
  14. James MF. Magnesium in obstetrics. Best Pract Res Clin Obstet Gynaecol. 2010;24(3):327-337.
  15. Blitz M, Blitz S, Beasely R, et al. Inhaled magnesium sulfate in the treatment of acute asthma. Cochrane Database Syst Rev. 2005;(4):CD003898.
  16. Jabbari A, Alijanpour E, Mir M, et al. Effects of nebulized magnesium sulfate on airway resistance after tracheal intubation. Iran J Allergy Asthma Immunol. 2013;12(1):67-73.
  17. Veyckemans F. Pharmacologic interventions for prevention and treatment of laryngospasm in children. Paediatr Anaesth. 2013;23(5):455-463.
  18. Kwak HJ, Kim JY, Lee KC, et al. Magnesium gargle and postoperative sore throat. Anesth Analg. 2010;111(2):404-407.
  19. Ahuja V, Mitra S, Sarna R. Nebulized ketamine and magnesium for prevention of POST. J Anaesthesiol Clin Pharmacol. 2013;29(4):496-500.
  20. Trabelsi W, Romdhani C, El Asmi M, et al. Intravenous magnesium sulfate for prevention of POST. Middle East J Anaesthesiol. 2013;22(6):571-576.
  21. Hurford WE. The use of topical anesthetics and anti-inflammatory agents to prevent POST. Anesthesiology Clin North Am. 2002;20(4):1035-1045.
  22. Sarrafzadeh J, et al. Preoperative nebulization techniques for airway comfort. Middle East J Anaesthesiol. 2012;21(4):529-536.
  23. Ogata J, Minami K, Horishita T, et al. Gargling with ketamine reduces POST. Anesth Analg. 2005;101(1):126-129.
  24. Biro P. Postoperative throat complaints. Curr Opin Anaesthesiol. 2013;26(2):136-142.
  25. Singh NP, et al. Anti-inflammatory role of magnesium in airway diseases. J Asthma. 2011;48(8):799-803.

 

Recommended Articles
Research Article
Effect of OM meditation on cardiovascular parameters in hypertensive patients
...
Published: 22/08/2025
Download PDF
Research Article
Endotracheal Size Estimation in Children: What is Latest? Different Methods and Correlation – A Prospective Observational Study
...
Published: 22/08/2025
Download PDF
Research Article
Operative Efficiency, Recovery Profile, and Complication Rates in Single-Incision Versus Multi-Port Laparoscopic Cholecystectomy
Published: 30/12/2024
Download PDF
Research Article
Influence of Ketogenic Diet on Gastric Functions, Motility, in Central Indian Subjects: A Case-Control Study on the
Published: 07/05/2024
Download PDF
Chat on WhatsApp
Copyright © EJCM Publisher. All Rights Reserved.